{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:09:12Z","timestamp":1794020952932,"version":"4.8.0"},"reference-count":298,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:p>The British Association for Psychopharmacology and the National Association of Psychiatric Intensive Care and Low Secure Units developed this joint evidence-based consensus guideline for the clinical management of acute disturbance. It includes recommendations for clinical practice and an algorithm to guide treatment by healthcare professionals with various options outlined according to their route of administration and category of evidence. Fundamental overarching principles are included and highlight the importance of treating the underlying disorder. There is a focus on three key interventions: de-escalation, pharmacological interventions pre-rapid tranquillisation and rapid tranquillisation (intramuscular and intravenous). Most of the evidence reviewed relates to emergency psychiatric care or acute psychiatric adult inpatient care, although we also sought evidence relevant to other common clinical settings including the general acute hospital and forensic psychiatry. We conclude that the variety of options available for the management of acute disturbance goes beyond the standard choices of lorazepam, haloperidol and promethazine and includes oral-inhaled loxapine, buccal midazolam, as well as a number of oral antipsychotics in addition to parenteral options of intramuscular aripiprazole, intramuscular droperidol and intramuscular olanzapine. Intravenous options, for settings where resuscitation equipment and trained staff are available to manage medical emergencies, are also included.<\/jats:p>","DOI":"10.1177\/0269881118776738","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T07:00:41Z","timestamp":1528441241000},"page":"601-640","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":70,"title":["Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisation"],"prefix":"10.1177","volume":"32","author":[{"given":"Maxine X","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisil N","family":"Sethi","sequence":"additional","affiliation":[{"name":"Maudsley Hospital, South London and Maudsley NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas RE","family":"Barnes","sequence":"additional","affiliation":[{"name":"The Centre for Psychiatry, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Dix","sequence":"additional","affiliation":[{"name":"Wotton Lawn Hospital, together NHS Foundation Trust, Gloucester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz","family":"Dratcu","sequence":"additional","affiliation":[{"name":"Maudsley Hospital, South London and Maudsley NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Fox","sequence":"additional","affiliation":[{"name":"National Association of Psychiatric Intensive Care Units, East Kilbride, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Garriga","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C","family":"Haste","sequence":"additional","affiliation":[{"name":"Mill View Hospital, Sussex Partnership NHS Foundation Trust, Hove, East Sussex, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai G","family":"Kahl","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hanover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lingford-Hughes","sequence":"additional","affiliation":[{"name":"The Centre for Psychiatry, Imperial College London, London, UK and Central North West London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamish","family":"McAllister-Williams","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"South West London and St Georges NHS Foundation Trust, London, UK and St George\u2019s University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Parker","sequence":"additional","affiliation":[{"name":"Central & North West London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brodie","family":"Paterson","sequence":"additional","affiliation":[{"name":"CALM Training Ltd, Menstrie, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Paton","sequence":"additional","affiliation":[{"name":"Oxleas NHS Foundation Trust, Dartford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiris","family":"Posporelis","sequence":"additional","affiliation":[{"name":"South London and Maudsley NHS Foundation Trust, London, UK and Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Taylor","sequence":"additional","affiliation":[{"name":"South London and Maudsley NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"V\u00f6llm","sequence":"additional","affiliation":[{"name":"Institute of Mental Health, School of Medicine, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Wilson-Jones","sequence":"additional","affiliation":[{"name":"Maudsley Hospital, South London and Maudsley NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Woods","sequence":"additional","affiliation":[{"name":"The Hellingly Centre, Forensic Health Care Services, Sussex Partnership NHS Foundation Trust, East Sussex, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,6,8]]},"reference":[{"key":"bibr1-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1192\/apt.12.2.100"},{"key":"bibr2-0269881118776738","volume-title":"Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances","author":"Abdulrahim D","year":"2015"},{"key":"bibr3-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.185.1.63"},{"key":"bibr4-0269881118776738","first-page":"44","volume":"7","author":"Al-Haddad MK","year":"1996","journal-title":"Arab J Psychiatry"},{"key":"bibr5-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/00131746-200301000-00005"},{"key":"bibr6-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/00131746-200511001-00002"},{"key":"bibr7-0269881118776738","first-page":"1","author":"Allen MH","year":"2001","journal-title":"Postgrad Med"},{"key":"bibr8-0269881118776738","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10m06011yel"},{"key":"bibr9-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1007\/BF00179201"},{"key":"bibr10-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1987.tb02759.x"},{"key":"bibr11-0269881118776738","first-page":"41","volume":"19","author":"Austen JD","year":"2005","journal-title":"Nursing Standard"},{"key":"bibr12-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1993.tb03329.x"},{"key":"bibr13-0269881118776738","first-page":"581","volume-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","author":"Babe KS","year":"1996","edition":"9"},{"key":"bibr14-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014609"},{"key":"bibr15-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1590\/S1516-44462011000100008"},{"key":"bibr16-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113503509"},{"key":"bibr17-0269881118776738","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1176\/ajp.149.4.506","volume":"149","author":"Barbee J","year":"1992","journal-title":"Am J Psychiatry"},{"key":"bibr18-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.5.672"},{"key":"bibr19-0269881118776738","doi-asserted-by":"publisher","DOI":"10.3109\/09540261.2011.606541"},{"key":"bibr20-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110391123"},{"key":"bibr21-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2017.10.009"},{"key":"bibr22-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12875"},{"key":"bibr23-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00230-9"},{"key":"bibr24-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.apnu.2016.05.005"},{"key":"bibr25-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1017\/S1742646413000198"},{"key":"bibr26-0269881118776738","volume-title":"Independent Inquiry into the Death of David Bennett","author":"Blofeld J","year":"2003"},{"key":"bibr27-0269881118776738","first-page":"CD010607","volume":"5","author":"Boelig RC","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr28-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2003.00031.x"},{"key":"bibr29-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510360044034"},{"key":"bibr30-0269881118776738","doi-asserted-by":"publisher","DOI":"10.7748\/mhp.17.9.36.e924"},{"key":"bibr31-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2015.05.001"},{"key":"bibr32-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2006.57.7.1022"},{"key":"bibr33-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1037\/tra0000107"},{"key":"bibr34-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1077(199801)13:1<17::AID-HUP937>3.0.CO;2-G"},{"key":"bibr35-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.120.9.905"},{"key":"bibr36-0269881118776738","first-page":"52","volume":"60","author":"Buckley PF","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"bibr37-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2014.10.016"},{"key":"bibr38-0269881118776738","volume-title":"Neurotoxic Side Effects of Prescription Drugs","author":"Burst JCM","year":"1996"},{"key":"bibr39-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1186\/1471-227X-10-14"},{"key":"bibr40-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.150227"},{"key":"bibr41-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-13-225"},{"key":"bibr42-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2011-200849"},{"key":"bibr43-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2015.03.016"},{"key":"bibr44-0269881118776738","volume-title":"Use of Antipsychotics and\/or Benzodiazepines as Rapid Tranquilization in In-patients of Mental Facilities and Emergency Departments: A Review of the Clinical Effectiveness and Guidelines","author":"Canadian Agency for Drugs and Technologies in Health","year":"2015"},{"key":"bibr45-0269881118776738","volume-title":"Monitoring the Mental Health Act in 2012\/13","author":"Care Quality Commission","year":"2014"},{"key":"bibr46-0269881118776738","first-page":"CD001943","volume":"17","author":"Chakrabarti A","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr47-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1185\/03007999009111492"},{"key":"bibr48-0269881118776738","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20040901-06"},{"key":"bibr49-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2012.07.118"},{"key":"bibr50-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199910000-00015"},{"key":"bibr51-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80094-2"},{"key":"bibr52-0269881118776738","first-page":"365","volume":"53","author":"Chin CN","year":"1998","journal-title":"Med J Malaysia"},{"key":"bibr53-0269881118776738","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0806a"},{"key":"bibr54-0269881118776738","first-page":"S114","volume":"38","author":"Chouinard G","year":"1993","journal-title":"Can J Psychiatry"},{"key":"bibr55-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199412000-00002"},{"key":"bibr56-0269881118776738","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1207"},{"key":"bibr57-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.55.3.290"},{"key":"bibr58-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(87)80179-8"},{"key":"bibr59-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1986.tb04302.x"},{"key":"bibr60-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2016.08.008"},{"key":"bibr61-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2016.1177652"},{"key":"bibr62-0269881118776738","unstructured":"Concordia International (2017) Summary of Product Characteristics \u2013 Haloperidol 5 mg\/ml Solution for Injection. London: Concordia International Rx (UK) Limited. Available at: https:\/\/www.medicines.org.uk\/emc\/product\/514 (accessed 27 March 2018)."},{"key":"bibr63-0269881118776738","volume":"11","author":"Cox L","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr64-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610214001963"},{"key":"bibr65-0269881118776738","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0315"},{"key":"bibr66-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/00131746-200601000-00005"},{"key":"bibr67-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-0979.2003.00293.x"},{"key":"bibr68-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1049\/htl.2014.0077"},{"key":"bibr69-0269881118776738","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020349"},{"key":"bibr70-0269881118776738","volume-title":"Positive and Proactive Care: Reducing the Need for Restrictive Interventions","author":"Department of Health","year":"2014"},{"key":"bibr71-0269881118776738","volume-title":"Mental Health Act 1983: Code of Practice","author":"Department of Health","year":"2015"},{"key":"bibr72-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114527361"},{"key":"bibr73-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511543593.006"},{"key":"bibr74-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.1.142"},{"key":"bibr75-0269881118776738","first-page":"CD003441","volume":"12","author":"Douglas-Hall P","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr76-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1177\/1744629508100495"},{"key":"bibr77-0269881118776738","unstructured":"Eli Lilly (2017a) Summary of Product Characteristics \u2013 Zyprexa Velotab orodispersible tablets (olanzapine). Indianapolis, IN: Eli Lilly Product and Medical Information. Available at: https:\/\/www.medicines.org.uk\/emc\/product\/7901 (accessed 28 March 2018)."},{"key":"bibr78-0269881118776738","volume-title":"Summary of Product Characteristics \u2013 Zyprexa 10 mg Powder for Injection (olanzapine)","author":"Eli Lilly","year":"2017"},{"key":"bibr79-0269881118776738","doi-asserted-by":"publisher","DOI":"10.3109\/15622970109039978"},{"key":"bibr80-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199705000-00009"},{"key":"bibr81-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.1.108"},{"key":"bibr82-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(15)30801-4"},{"key":"bibr83-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1977.tb00226.x"},{"key":"bibr84-0269881118776738","unstructured":"Galen Ltd (2018) Summary of Product Characteristics \u2013 Adasuve (loxapine). Craigavon: Galen Ltd. Available at: https:\/\/www.medicines.org.uk\/emc\/product\/7332 (revised January 2018) (accessed 27 March 2018)."},{"key":"bibr85-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1080\/13651500510029011"},{"key":"bibr86-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-007-0532-3"},{"key":"bibr87-0269881118776738","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2015.1132007"},{"key":"bibr88-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.106.034538"},{"key":"bibr89-0269881118776738","volume-title":"Strategies to De-escalate Aggressive Behavior in Psychiatric Patients. AHRQ Comparative Effectiveness Reviews","author":"Gaynes BN","year":"2016"},{"key":"bibr90-0269881118776738","unstructured":"General Medical Council (2013) Prescribing Guidance: Prescribing Unlicensed Medicines. London: General Medical Council. Available at: https:\/\/www.gmc-uk.org\/guidance\/ethical_guidance\/14327.asp (accessed 22 March 2018)."},{"key":"bibr91-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1007\/s11126-011-9178-y"},{"key":"bibr92-0269881118776738","volume-title":"Guidelines for the Management of Excited Delirium\/Acute Behavioural Disturbance (ABD)","author":"Gillings M","year":"2016"},{"key":"bibr93-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.11.1774"},{"key":"bibr94-0269881118776738","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4088\/JCP.v60n0112c","volume":"60","author":"Glazer WM","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"bibr95-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116636545"},{"key":"bibr96-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2013.1114"},{"key":"bibr97-0269881118776738","doi-asserted-by":"publisher","DOI":"10.3109\/15622970903555881"},{"key":"bibr98-0269881118776738","first-page":"534","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy WA","year":"1976"},{"key":"bibr99-0269881118776738","first-page":"217","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy WA","year":"1976"},{"key":"bibr100-0269881118776738","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262110-00006"},{"key":"bibr101-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1517\/17425250902911455"},{"key":"bibr102-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/inm.12136"},{"key":"bibr103-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2017.07.003"},{"key":"bibr104-0269881118776738","volume-title":"Safewards Victorian Trial Final Evaluation Report","author":"Hamilton B","year":"2016"},{"key":"bibr105-0269881118776738","first-page":"393","volume":"13","author":"Hardy S","year":"2017","journal-title":"Ment Health Fam Med"},{"key":"bibr106-0269881118776738","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2012.696143"},{"key":"bibr107-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2008.03.004"},{"key":"bibr108-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1017\/S1742646412000301"},{"key":"bibr109-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2004.07.001"},{"key":"bibr110-0269881118776738","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2011.9.6865"},{"key":"bibr111-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2015.02.019"},{"key":"bibr112-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181db8715"},{"key":"bibr113-0269881118776738","first-page":"CD005146","volume":"3","author":"Huf G","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr114-0269881118776738","first-page":"CD005146","volume":"11","author":"Huf G","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr115-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39339.448819.AE"},{"key":"bibr116-0269881118776738","first-page":"11","volume-title":"Commentary on the DIEPSS and Guide to its Usage","author":"Inada T","year":"1996"},{"key":"bibr117-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1017\/S1742646413000277"},{"key":"bibr118-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1017\/S1742646411000057"},{"key":"bibr119-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1017\/S174264641200026X"},{"key":"bibr120-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2010.05.037"},{"key":"bibr121-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2015.11.028"},{"key":"bibr122-0269881118776738","first-page":"853","volume":"11","author":"Iancu I","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"bibr123-0269881118776738","unstructured":"Janssen-Cilag (2017) Summary of Product Characteristics \u2013 Risperdal Quicklet Oro-dispersible tablets (risperidone). High Wycombe: Janssen-Cilag Ltd. Available at https:\/\/www.medicines.org.uk\/emc\/product\/6862 (revised September 2017) (accessed 28 March 2018)."},{"key":"bibr124-0269881118776738","first-page":"CD000525","volume":"4","author":"Jayakody K","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr125-0269881118776738","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2017"},{"key":"bibr126-0269881118776738","unstructured":"Joint Formulary Committee (2018) Flumazenil. In: British National Formulary (online). London: BMJ Group and Pharmaceutical Press. Available at: http:\/\/www.medicinescomplete.com (accessed 22 March 2018)."},{"key":"bibr127-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1038\/srep10494"},{"key":"bibr128-0269881118776738","unstructured":"Kasper S, Baranyi A, Eisenburger P, et al. (2013) Die Behandlung der Agitation beim psychiatrischen Notfall. Konsensus-Statement \u2013 State of the art 2013. Clini Cum Neuropsy Sonderausgabe. http:\/\/medizin-akademie.at\/wp-content\/uploads\/2014\/06\/low_Kons_Agitation_psychNotfall_psy0513_jh2.pdf"},{"key":"bibr129-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/13.2.261"},{"key":"bibr130-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/16.3.537"},{"key":"bibr131-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198809000-00008"},{"key":"bibr132-0269881118776738","first-page":"305","volume":"54","author":"Keck PE","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"bibr133-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1177\/026988119701100311"},{"key":"bibr134-0269881118776738","doi-asserted-by":"publisher","DOI":"10.3109\/10903127.2014.942478"},{"key":"bibr135-0269881118776738","first-page":"CD002830","volume":"12","author":"Khokhar MA","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr136-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31818aaf6c"},{"key":"bibr137-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2015.07.005"},{"key":"bibr138-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2005.07.003"},{"key":"bibr139-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1002\/cbm.826"},{"key":"bibr140-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/inm.12389"},{"key":"bibr141-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2011.00975.x"},{"key":"bibr142-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2006.09.003"},{"key":"bibr143-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2016.01.024"},{"key":"bibr144-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.13239"},{"key":"bibr145-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000138820.78121.0e"},{"key":"bibr146-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.136.8.1061"},{"key":"bibr147-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.110.081513"},{"key":"bibr148-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1159\/000315437"},{"key":"bibr149-0269881118776738","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0207"},{"key":"bibr150-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112444324"},{"key":"bibr151-0269881118776738","first-page":"202","volume":"6","author":"Liu P","year":"1997","journal-title":"Chinese Journal of Pharmacoepidemiology"},{"key":"bibr152-0269881118776738","first-page":"380","volume":"5","author":"Lowert AC","year":"1989","journal-title":"Pharmatherapeutica"},{"key":"bibr153-0269881118776738","first-page":"4","volume":"112","author":"Lowry M","year":"2016","journal-title":"Nurs Times"},{"key":"bibr154-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1017\/S1742646412000295"},{"key":"bibr155-0269881118776738","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v5.i2.182"},{"key":"bibr156-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2005.10.002"},{"key":"bibr157-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1192\/apt.11.6.404"},{"key":"bibr158-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.122596"},{"key":"bibr159-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182900fd6"},{"key":"bibr160-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1197\/j.aem.2005.07.017"},{"key":"bibr161-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12842"},{"key":"bibr162-0269881118776738","first-page":"CD007575","volume":"9","author":"Matthews A","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr163-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/jpm.12310"},{"key":"bibr164-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0704(05)70185-8"},{"key":"bibr165-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1177\/0269881117699361"},{"key":"bibr166-0269881118776738","first-page":"232","volume":"270","author":"McElhatton PR","year":"2010","journal-title":"Pharm J"},{"key":"bibr167-0269881118776738","first-page":"142","volume":"57","author":"McElroy SL","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"bibr168-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1159\/000118970"},{"key":"bibr169-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-33965-8_12"},{"key":"bibr170-0269881118776738","unstructured":"Medicines and Healthcare products Regulatory Agency (2009) Off-label or unlicensed use of medicines: prescribers\u2019 responsibilities. Drug Safety Update April 2009, 2: 6."},{"key":"bibr171-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200108000-00006"},{"key":"bibr172-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(01)00365-7"},{"key":"#cr-split#-bibr173-0269881118776738.1","unstructured":"Mental Health Network (2014) Positive and Proactive Care: Reducing the Need for Restrictive Intervention. London: Mental Health Network, NHS Confederation, Briefing"},{"key":"#cr-split#-bibr173-0269881118776738.2","unstructured":"September 2014, Issue 277. http:\/\/www.nhsconfed.org\/-\/media\/Confederation\/Files\/Publications\/Documents\/Positive-and-proactive-care.pdf?dl=1"},{"key":"bibr174-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2003.111"},{"key":"bibr175-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000018"},{"key":"bibr176-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.03.004"},{"key":"bibr177-0269881118776738","first-page":"301","volume":"36","author":"Moyano CZ","year":"1975","journal-title":"Dis Nerv Syst"},{"key":"bibr178-0269881118776738","first-page":"169","volume":"15","author":"Mukherjee S","year":"1994","journal-title":"Am J Psychiatry"},{"key":"bibr179-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2017.04.026"},{"key":"bibr180-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/inm.12012"},{"key":"bibr181-0269881118776738","volume-title":"National Minimum Standards for Psychiatric Intensive Care in General Adult Services","author":"National Association of Psychiatric Intensive Care and Low Secure Units","year":"2014"},{"key":"bibr182-0269881118776738","volume-title":"NAPICU Position on the Monitoring, Regulation and Recording of the Extra Care Area, Seclusion and Long-term Segregation Use in the Context of the Mental Health Act 1983: Code of Practice (2015)","author":"National Association of Psychiatric Intensive Care and Low Secure Units","year":"2016"},{"key":"bibr183-0269881118776738","volume-title":"Violence: The Short-Term Management of Disturbed and Violent Behaviour in Inpatient Psychiatric Settings and Emergency Departments","author":"National Institute for Health and Care Excellence","year":"2005"},{"key":"bibr184-0269881118776738","volume-title":"Dementia: Supporting People with Dementia and Their Carers in Health and Social Care","author":"National Institute for Health and Care Excellence","year":"2006"},{"key":"bibr185-0269881118776738","volume-title":"Antenatal Care: Routine Care for the Healthy Pregnant Woman","author":"National Institute for Health and Care Excellence","year":"2008"},{"key":"bibr186-0269881118776738","volume-title":"Guidance on the Use of Electroconvulsive Therapy","author":"National Institute for Health and Care Excellence","year":"2009"},{"key":"bibr187-0269881118776738","volume-title":"Alcohol-use Disorders: Diagnosis and Management of Physical Complications","author":"National Institute for Health and Care Excellence","year":"2010"},{"key":"bibr188-0269881118776738","volume-title":"Alcohol Dependence and Harmful Alcohol Use","author":"National Institute for Health and Care Excellence","year":"2011"},{"key":"bibr189-0269881118776738","volume-title":"Patient Experience in Adult NHS Services: Improving the Experience of Care for People Using Adult NHS Services","author":"National Institute for Health and Care Excellence","year":"2012"},{"key":"bibr190-0269881118776738","volume-title":"Loxapine Inhalation for Treating Acute Agitation and Disturbed Behaviours Associated with Schizophrenia and Bipolar Disorder (Terminated Appraisal)","author":"National Institute for Health and Care Excellence","year":"2013"},{"key":"bibr191-0269881118776738","volume-title":"Psychosis and Schizophrenia in Adults: Prevention and Management","author":"National Institute for Health and Care Excellence","year":"2014"},{"key":"bibr192-0269881118776738","volume-title":"Bipolar Disorder: Assessment and Management","author":"National Institute for Health and Care Excellence","year":"2014"},{"key":"bibr193-0269881118776738","volume-title":"Antenatal and Postnatal Mental Health: Clinical Management and Service Guidance","author":"National Institute for Health and Care Excellence","year":"2014"},{"key":"bibr194-0269881118776738","volume-title":"Rapid Tranquillisation in Mental Health Settings: Promethazine Hydrochloride","author":"National Institute for Health and Care Excellence","year":"2014"},{"key":"bibr195-0269881118776738","volume-title":"Management of Aggression, Agitation and Behavioural Disturbances in Dementia: Valproate Preparations","author":"National Institute for Health and Care Excellence","year":"2015"},{"key":"bibr196-0269881118776738","volume-title":"Violence and Aggression: Short-term Management in Mental Health, Health and Community Settings","author":"National Institute for Health and Care Excellence","year":"2015"},{"key":"bibr197-0269881118776738","volume-title":"Challenging Behaviour and Learning Disabilities: Prevention and Interventions for People with Learning Disabilities Whose Behaviour Challenges","author":"National Institute for Health and Care Excellence","year":"2015"},{"key":"bibr198-0269881118776738","volume-title":"Antenatal and Postnatal Mental Health","author":"National Institute for Health and Care Excellence","year":"2016"},{"key":"bibr199-0269881118776738","volume-title":"Bipolar Disorder: Assessment and Management","author":"National Institute for Health and Care Excellence","year":"2016"},{"key":"bibr200-0269881118776738","volume-title":"Violent and Aggressive Behaviours in People with Mental Health Problems","author":"National Institute for Health and Care Excellence","year":"2017"},{"key":"bibr201-0269881118776738","unstructured":"National Library of Medicine Toxnet (2018) Hazardous Substances Data Bank (HSDB): Promethazine. CASRN: 60-87-7\/ 58-33-3. Bethesda: US National Library of Medicine. Available at: https:\/\/toxnet.nlm.nih.gov (accessed 27 March 2018)."},{"key":"bibr202-0269881118776738","unstructured":"National Patient Safety Agency (2007) Patient Safety Alert 20: Promoting Safer Use of Injectable Medicines. London: National Patient Safety Agency. Available at: http:\/\/www.nrls.npsa.nhs.uk\/resources\/?entryid45=59812"},{"key":"bibr203-0269881118776738","unstructured":"National Patient Safety Agency (2008a) Reducing Risk of Overdose with Midazolam Injection in Adults. Rapid Response Report NPSA\/2008\/RRR011. London: National Patient Safety Agency. Available at: http:\/\/www.nrls.npsa.nhs.uk\/resources\/?EntryId45=59896 (accessed 24 March 2018)."},{"key":"bibr204-0269881118776738","unstructured":"National Patient Safety Agency (2008b) Reducing Risk of Overdose with Midazolam Injection in Adults: Supporting Information. Rapid Response Report NPSA\/2008\/RRR011. London: National Patient Safety Agency. Available at: http:\/\/www.nrls.npsa.nhs.uk\/resources\/?EntryId45=59896 (accessed 24 March 2018)."},{"key":"bibr205-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.nedt.2008.08.011"},{"key":"bibr206-0269881118776738","unstructured":"NHS Litigation Authority (2013) NHS LA Risk Management Standards 2013-14. NHS Litigation Authority. Available at: http:\/\/www.nhsla.com\/Pages\/Publications.aspx?library=safety%7cstandards (accessed 24 March 2018)."},{"key":"bibr207-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1197\/j.aem.2003.06.015"},{"key":"bibr208-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0130-3"},{"key":"bibr209-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.jen.2015.09.017"},{"key":"bibr210-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0197-8"},{"key":"bibr211-0269881118776738","volume":"7","author":"Ostinelli EG","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr212-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008074.pub2"},{"key":"bibr213-0269881118776738","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1962.10.3.799"},{"key":"bibr214-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcn153"},{"key":"bibr215-0269881118776738","first-page":"80","volume":"21","author":"Paprocki J","year":"1977","journal-title":"Curr Ther Res Clin Exp"},{"key":"bibr216-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2014.03.010"},{"key":"bibr217-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1192\/pb.26.12.460"},{"key":"bibr218-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.042895"},{"key":"bibr219-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-349-13577-6_6"},{"key":"bibr220-0269881118776738","first-page":"58","volume":"93","author":"Paterson B","year":"1997","journal-title":"Nurs Times"},{"key":"bibr221-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.13060787"},{"key":"bibr222-0269881118776738","unstructured":"Pfizer Ltd (2014) Summary of Product Characteristics \u2013 Ativan Injection (lorazepam). Available at: https:\/\/www.medicines.org.uk\/emc\/product\/5473 (accessed 27 March 2018)."},{"key":"bibr223-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.160.6.831"},{"key":"bibr224-0269881118776738","volume-title":"Topic 16a. Rapid Tranquillisation in the Context of the Pharmacological Management of Acutely-disturbed Behaviour","author":"POMH-UK","year":"2017"},{"key":"bibr225-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.02.005"},{"key":"bibr226-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810250064008"},{"key":"bibr227-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-015-0053-3"},{"key":"bibr228-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0349.2011.00793.x"},{"key":"bibr229-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.144576"},{"key":"bibr230-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2017.10.002"},{"key":"bibr231-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201200393"},{"key":"bibr232-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39341.608519.BE"},{"key":"bibr233-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02035-3"},{"key":"bibr234-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(98)00045-6"},{"key":"bibr235-0269881118776738","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2011.9.6864"},{"key":"bibr236-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-33965-8_7"},{"key":"bibr237-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.02.026"},{"key":"bibr238-0269881118776738","volume-title":"Congres de Psychiatrie et de Neurolgie de Langue Francaise, LXXXVIth Session","author":"Ropert R","year":"1988"},{"key":"bibr239-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1007\/BF02311185"},{"key":"bibr240-0269881118776738","unstructured":"Royal College of Nursing (2016) Positive and Proactive Care: Reducing the Need for Restrictive Interventions. London: Royal College of Nursing. Available at: https:\/\/www.rcn.org.uk\/professional-development\/publications\/pub-005459 (accessed 24 March 2018)."},{"key":"bibr241-0269881118776738","volume-title":"The Management of Nausea and Vomiting of Pregnancy and Hyperemesis Gravidarum","author":"Royal College of Obstetricians and Gynaecologists","year":"2016"},{"key":"bibr242-0269881118776738","unstructured":"Royal College of Physicians (2017) National Early Warning Score (NEWS) 2. London: Royal College of Physicians. Available at: https:\/\/www.rcplondon.ac.uk\/projects\/outputs\/national-early-warning-score-news-2 (accessed 4 January 2018)."},{"key":"bibr243-0269881118776738","volume-title":"Use of Licensed Medicines for Unlicensed Applications in Psychiatric Practice","author":"Royal College of Psychiatrists","year":"2007"},{"key":"bibr244-0269881118776738","volume-title":"Prevention and Management of Violence: Guidance for Mental Healthcare Professionals","author":"Royal College of Psychiatrists","year":"2013"},{"key":"bibr245-0269881118776738","unstructured":"Royal College of Psychiatrists (2014) Consensus Statement on High-dose Antipsychotic Medication. College Report CR190. London: Royal College of Psychiatrists. Available at: http:\/\/www.rcpsych.ac.uk\/files\/pdfversion\/CR190.pdf (accessed 24 March 2018)."},{"key":"bibr246-0269881118776738","volume-title":"Use of Licensed Medicines for Unlicensed Applications in Psychiatric Practice","author":"Royal College of Psychiatrists Psychopharmacology Committee","year":"2017","edition":"2"},{"key":"bibr247-0269881118776738","unstructured":"Sanofi (2016) Summary of Product Characteristics \u2013 Phenergan 25 mg\/ml Solution for Injection (promethazine hydrochloride). Available at: https:\/\/www.medicines.org.uk\/emc\/medicine\/1669 (accessed 27 March 2018)."},{"key":"bibr248-0269881118776738","unstructured":"Sanofi (2017) Summary of Product Characteristics \u2013 Nozinan 25 mg Tablets (levomepromazine maleate). Available at: https:\/\/www.medicines.org.uk\/emc\/product\/1429 (accessed 27 March 2018)."},{"key":"bibr249-0269881118776738","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n1204"},{"key":"bibr250-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1017\/S1049023X16000662"},{"key":"bibr251-0269881118776738","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2014.9.23229"},{"key":"bibr252-0269881118776738","first-page":"CD008191","volume":"2","author":"Seitz DP","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr253-0269881118776738","first-page":"645","volume":"19","author":"Selman FB","year":"1976","journal-title":"Curr Ther Res Clin Exp"},{"key":"bibr254-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7183.593"},{"key":"bibr255-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000222516.56143.b1"},{"key":"bibr256-0269881118776738","first-page":"CD007779","volume":"10","author":"Sivaraman P","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr257-0269881118776738","first-page":"31","volume":"60","author":"Stahl SM","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"bibr258-0269881118776738","unstructured":"Stahl SM (2013) Stahl\u2019s Essential Psychopharmacology. 4th ed. New York, NY: Cambridge University Press, 628 pp."},{"key":"bibr259-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852915000784"},{"key":"bibr260-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12222"},{"key":"bibr261-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2376"},{"key":"bibr262-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3956(01)00052-8"},{"key":"bibr263-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(13)76907-4"},{"key":"bibr264-0269881118776738","volume-title":"The Bethlem and Maudsley NHS Trust Prescribing Guidelines 1999","author":"Taylor D","year":"1999","edition":"5"},{"key":"bibr265-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1080\/13651500802233886"},{"key":"bibr266-0269881118776738","volume-title":"The Maudsley Prescribing Guidelines","author":"Taylor D","year":"2015","edition":"12"},{"key":"bibr267-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2003.02078.x"},{"key":"bibr268-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2016.07.033"},{"key":"bibr269-0269881118776738","first-page":"1301","volume":"85","author":"Taymeeyapradit U","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"bibr270-0269881118776738","volume-title":"Joint Commission on Accreditation of Healthcare Organizations: Getting a Handle on Restraint: New Behavioural Health Care Standards Spell Out Specifics of Training","author":"The Joint Commission","year":"2000"},{"key":"bibr271-0269881118776738","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0115"},{"key":"bibr272-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7417.708"},{"key":"bibr273-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000124"},{"key":"bibr274-0269881118776738","first-page":"126","volume":"47","author":"Tuason VB","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"bibr275-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852915000279"},{"key":"bibr276-0269881118776738","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3928\/0279-3695-19900601-04","volume":"28","author":"Turnbull J","year":"1990","journal-title":"J Psychosocial Nurs Ment Health Serv"},{"key":"bibr277-0269881118776738","unstructured":"UK Medicines Information (2014) What should you Think About When Prescribing to Pregnant Women? London: UK Medicines Information. Available at: https:\/\/www.sps.nhs.uk\/wp-content\/uploads\/2014\/12\/QA34_6_PregnancyPrescribing.doc"},{"key":"bibr278-0269881118776738","unstructured":"UK Teratology Information Service (2014) Use of Haloperidol in Pregnancy. London: UK Teratology Information Service. Available at: http:\/\/www.medicinesinpregnancy.org\/bumps\/monographs\/USE-OF-HALOPERIDOL-IN-PREGNANCY\/"},{"key":"bibr279-0269881118776738","doi-asserted-by":"crossref","unstructured":"Uys H, Berk M (1996) A controlled double blind study of zuclopenthixol acetate compared with clothiapine in acute psychosis including mania and exacerbation of chronic psychosis. Proceedings of XXth Collegium Internationale Neuro-psychopharmacologicum, 23-27 June 1996, Melbourne, Australia.","DOI":"10.1016\/0924-977X(96)87580-8"},{"key":"bibr280-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/00131746-200603000-00005"},{"key":"bibr281-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.09.007"},{"key":"bibr282-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01797.x"},{"key":"bibr283-0269881118776738","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10m06529"},{"key":"bibr284-0269881118776738","first-page":"CD004028","volume":"11","author":"Wang Y","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr285-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.116.192799"},{"key":"bibr286-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-8-61"},{"key":"bibr287-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.17040472"},{"key":"bibr288-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2011.01.024"},{"key":"bibr289-0269881118776738","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2011.9.6866"},{"key":"bibr290-0269881118776738","unstructured":"Wockhardt UK Ltd (2017) Summary of Product Characteristics \u2013 Levomepromazine hydrochloride 25mg\/ml Solution for Injection. Available at: https:\/\/www.medicines.org.uk\/emc\/product\/3014 (accessed 27 March 2018)."},{"key":"bibr291-0269881118776738","volume-title":"Global Status Report on Violence Prevention 2014","author":"World Health Organization","year":"2014"},{"key":"bibr292-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1111\/add.13780"},{"key":"bibr293-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.143.1.35"},{"key":"bibr294-0269881118776738","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n1219c"},{"key":"bibr295-0269881118776738","volume":"12","author":"Zaman H","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr296-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.8.856"},{"key":"bibr297-0269881118776738","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b13e318033bd5e"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881118776738","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0269881118776738","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881118776738","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:07:44Z","timestamp":1777507664000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0269881118776738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":298,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1177\/0269881118776738"],"URL":"https:\/\/doi.org\/10.1177\/0269881118776738","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}